Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.
MarketWatch
SeekingAlpha
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.